MariMed

MRMD · OTC

$0.0555−$0.0015 (−2.63%)TodayMarket closed ·
Prev close $0.057

Latest news

  • Press releaseGlobe Newswire

    MariMed Announces Third Quarter 2026 Earnings Date

  • Press releaseGlobe Newswire

    MariMed Files Definitive Proxy Statement for Special Meeting of Stockholders to Approve Proposed Reverse Stock Split

  • Press releaseGlobe Newswire

    MariMed Reports Second Quarter 2026 Earnings

  • Press releaseGlobe Newswire

    MariMed Announces Second Quarter 2026 Earnings Date

  • News

    MariMed Q1 2026 Earnings Call: Complete Transcript

  • Press releaseGlobe Newswire

    MariMed Reports First Quarter 2026 Earnings

  • Press releaseGlobe Newswire

    MariMed Announces First Quarter 2026 Earnings Date

  • News

    MariMed Q4 Adj. EPS $0.01 Beats $(0.01) Estimate, Sales $41.650M Beat $40.600M Estimate.

  • Press releaseGlobe Newswire

    MariMed Reports Fourth Quarter and Full Year 2025 Earnings

  • News

    An Overview of MariMed's Earnings

  • Press releaseGlobe Newswire

    MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date

  • Press releaseGlobe Newswire

    MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island

  • Press releaseGlobe Newswire

    MariMed Reports Third Quarter 2025 Earnings

  • Press releaseGlobe Newswire

    MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers

  • Press releaseGlobe Newswire

    MariMed Announces Strategic Exit From Missouri Market

  • Press releaseGlobe Newswire

    MariMed To Expand Brand Distribution To New York

  • Press releaseGlobe Newswire

    MariMed Reports Second Quarter 2025 Earnings

  • NewsJavier Hasse

    This Week In Cannabis: Earnings Divide The Market As DEA, Brands And Bills Move Forward

  • NewsJavier Hasse

    The Week In Cannabis: Delays, Decrees And Deals Reshape The Global Playbook

  • NewsJavier Hasse

    This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations

  • NewsJavier Hasse

    This Week In Cannabis: Snoop's Beverage Empire, Earnings, M&A, International News And More

  • NewsJavier Hasse

    Cannabis Co. MariMed Finalizes $11M Deal To Acquire First State Compassion

  • NewsNicolás Jose Rodriguez

    Is MariMed A Safe Haven In The Wake Of Florida's Cannabis Legalization Defeat?

  • NewsNina Zdinjak

    MariMed's Q3 Revenue Slightly Up YoY As Net Loss Improves, Revises Guidance

  • NewsNina Zdinjak

    Cannabis Company Launches Veterans Aid: $5K Grants For Housing Relief In Key Markets

  • NewsNicolás Jose Rodriguez

    Edibles Surge In The Heartland: MariMed's Play For Missouri And Illinois Cannabis Dominance

  • NewsNicolás Jose Rodriguez

    Can MariMed's $7.7M Illinois Cannabis Expansion Turn The Tide In A $496M Market?

  • NewsRolando García

    Almost Every Major Cannabis Company Could See Positive Cash Flow If 280E Is Removed In 2025

  • NewsJelena Martinovic

    EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts Say

  • NewsJelena Martinovic

    These Two Marijuana Giants Will Soon Report Earnings, Hear From CEOs At Benzinga Cannabis Conference

  • NewsNicolás Jose Rodriguez

    Don't Let Hidden Debt Fool You: How Cannabis Investors Can Tell If They Are Safe

  • NewsNicolás Jose Rodriguez

    Cheaper Than A Big Mac: Weed Penny Stocks Emerge As Winners Amidst Market Downturn

  • NewsJelena Martinovic

    Here's Where To Buy Legal Weed: Khalifa Kush's Store In Las Vegas, West Hollywood's LGBTQ+ Owned Cannabis Dispensary And More

  • NewsJelena Martinovic

    CEO Shake-Ups At Canopy, Curaleaf And Recent Top Exec And Board Changes In Cannabis And Psychedelics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.